n-hexadecane has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elias, PM; Feingold, KR; Mao-Qiang, M; Menon, GK; Schaude, M | 1 |
1 other study(ies) available for n-hexadecane and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
Topics: Alkanes; Animals; Cell Membrane Permeability; Cholesterol; Dermatitis; Epidermis; Fatty Acids, Monounsaturated; Fluvastatin; Histocytochemistry; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lanthanum; Lipase; Lovastatin; Male; Mice; Mice, Hairless; Skin; Tetradecanoylphorbol Acetate; Up-Regulation | 1992 |